Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,071,070
in 6 filings, $11.0M under 10b5-1 plans

Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-24 Olwill Shane Chief Development Officer Grant or award · Stock Option (Right to buy) +249,080 249,080
2022-02-22 Olwill Shane Chief Development Officer Grant or award · Stock Option (Right to buy) +215,819 215,819
2021-08-30 Olwill Shane Chief Development Officer Exercise or conversion +38,400 $1.52 $58K 43,038
2021-08-30 Olwill Shane Chief Development Officer Sale −9,200 $5.00 $46K 33,838
2021-08-30 Olwill Shane Chief Development Officer Sale −29,200 $5.15 $150K 4,638
2021-08-30 Olwill Shane Chief Development Officer Exercise or conversion · Stock Option (right to buy) −38,400 61,600

Page 1 of 1 · 6 trades